Published in Eur J Haematol on April 01, 1992
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Ann Rheum Dis (2014) 0.88
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry (1983) 6.38
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry (1983) 2.32
The important role of neuropeptides in complex regional pain syndrome. Neurology (2001) 1.88
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet (1998) 1.73
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry (1983) 1.56
Long-term storage of samples for flow cytometric DNA analysis. Cytometry (1983) 1.36
Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis. Cancer Res (1982) 1.18
Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet (1987) 1.15
Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. Eur J Nucl Med (2000) 1.10
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain (2000) 1.09
Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res (1980) 1.05
Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats. Cell Prolif (2000) 1.04
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia. Acta Pathol Microbiol Scand A (1973) 1.02
A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer (1983) 1.02
Membrane transport of anthracyclines. Pharmacol Ther (1982) 1.00
Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med (1988) 0.99
Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scand J Clin Lab Invest (1996) 0.99
Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol (2001) 0.99
Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression. Eur J Haematol (1989) 0.98
Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF. Eur J Clin Invest (1992) 0.98
Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer (1981) 0.94
Growth stimulation of human bone marrow cells in agar culture by vascular cells. Blood (1975) 0.94
Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol (1991) 0.94
Mechanism of resistance to anthracyclines and vinca alkaloids. Prog Clin Biol Res (1983) 0.93
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment. Cancer (1988) 0.91
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res (1979) 0.91
Haemodynamic response to exercise in patients with alcoholic liver cirrhosis. Clin Physiol (1987) 0.90
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). Cancer (1980) 0.89
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle. Cancer Treat Rev (1984) 0.89
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells. Cancer Chemother Pharmacol (1987) 0.88
Plasma levels of parathyroid hormone, vitamin D, calcitonin, and calcium in association with endurance exercise. Calcif Tissue Int (1993) 0.88
Changing electrocardiographic findings in pulmonary embolism in relation to vascular obstruction. Cardiology (1989) 0.88
Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology (2000) 0.88
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide. Eur J Cancer Clin Oncol (1988) 0.87
Synchronization of the human promyelocytic cell line HL 60 by thymidine. Cell Tissue Kinet (1986) 0.87
Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache. Cephalalgia (2003) 0.86
Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol (1985) 0.86
PHASE I clinical trial of an oral solution of VP-16-213. Cancer Treat Rep (1976) 0.84
Total body and splanchnic thermogenesis in curarized man during a short exposure to cold. Acta Anaesthesiol Scand (1980) 0.84
Thyroid function in malignant lymphoma. Acta Med Scand (1977) 0.83
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease. Cancer Treat Rep (1982) 0.83
Treatment of pulmonary embolism with full-dose heparin, streptokinase or embolectomy--results and indications. Thorac Cardiovasc Surg (1986) 0.83
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. Cancer Chemother Rep (1972) 0.83
Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma. J Am Acad Dermatol (1986) 0.83
Bronchial artery perfusion scintigraphy to assess bronchial artery blood flow after lung transplantation. J Nucl Med (1999) 0.83
Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor. Cancer Chemother Pharmacol (1992) 0.83
Left ventricular performance in alcoholic patients without chronic liver disease. Br Heart J (1987) 0.83
Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor. Eur J Haematol (1993) 0.82
Ewing's tumor following bilateral retinoblastoma. A case report. Cancer (1983) 0.82
Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis. Scand J Gastroenterol (1996) 0.82
Increased arterial compliance in decompensated cirrhosis. J Hepatol (1999) 0.82
Fatal hepatitis following irradiation and vincristine. Acta Med Scand (1982) 0.82
A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas. Leuk Lymphoma (1992) 0.81
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review. Recent Results Cancer Res (1980) 0.81
Effect of age on therapeutic response and survival in advanced Hodgkin's disease. Cancer Treat Rep (1982) 0.81
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. Leukemia (1995) 0.81
Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent. Cancer Chemother Rep (1972) 0.81
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies. Cancer Treat Rep (1982) 0.80
Immunohistochemical identification of lymphocyte subsets and accessory cells in human hyperplastic lymph nodes. The functional significance of the compartmentalization of lymphoid tissue. Scand J Haematol (1984) 0.80
CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist. Br J Pharmacol (2001) 0.80
Abolished production of interferon by leucocytes of patients with the acquired cytogenetic abnormalities 5q -- or -- 5 in secondary and de-novo acute non-lymphocytic leukaemia. Br J Haematol (1980) 0.80
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B. J Clin Oncol (1986) 0.80
Anticoagulant treatment of acute coronary thrombosis. Acta Med Scand (1969) 0.80
Diurnal variation in blood pressure in patients with biventricular assist devices and retained, nonpumping native hearts. Circulation (1994) 0.80
Ethanol elimination kinetics in human liver and pig liver in vivo. Am J Physiol (1979) 0.79
Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol (1996) 0.79
Prognostic significance of tumour burden in Hodgkin's disease PS I and II. Scand J Haematol (1986) 0.79
Daunorubicin in the therapy of acute granulocytic leukemia. Cancer Res (1973) 0.79
Haematological effects from radioiodine treatment of thyroid carcinoma. Acta Oncol (1990) 0.79
Prophylactic vancomycin versus placebo in arterial prosthetic reconstructions. Thorac Cardiovasc Surg (1985) 0.79
Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines. Exp Hematol (1996) 0.79
Metabolic studies in man with mycophenolic acid (NSC-129185), a new antitumor agent. Cancer Chemother Rep (1972) 0.79
Non-sulphated cholecystokinin in human medullary thyroid carcinomas. J Endocrinol (1990) 0.79
Prognostic factors in Hodgkin's disease stage IV. Eur J Haematol (1988) 0.79
Immune marker expression in 53 lymphomas of high-grade malignancy. Histopathology (1983) 0.79
Clinical experience with bacteraemia in patients with leukaemia and allied neoplastic diseases. Chemotherapy (1978) 0.78
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells. Br J Cancer (1993) 0.78
Interaction between normal and leukaemic human cells in agar culture. Scand J Haematol (1976) 0.78
Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy. Acta Med Scand (1983) 0.78
The development of medullary carcinoma of the thyroid does not involve the loss of alleles on the short arm of chromosome 11. Br J Cancer (1987) 0.78
Level and diurnal variations of hormones of interest to the cardiovascular system in patients with heart transplants. Am J Cardiol (1992) 0.78
Serum lipoprotein inhibitors of granulopoiesis in human bone marrow cultures. Exp Hematol (1979) 0.78
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B. Cancer (1993) 0.78
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. Cancer Treat Rep (1984) 0.78
Anthracycline resistance. Acta Oncol (1989) 0.78
Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark. Dan Med Bull (1991) 0.78
Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid (2002) 0.77
Washless double staining of unfixed nuclei for flow cytometric analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine). Cytometry (1991) 0.77